Literature DB >> 10961468

Urinary phytate in calcium oxalate stone formers and healthy people--dietary effects on phytate excretion.

F Grases1, J G March, R M Prieto, B M Simonet, A Costa-Bauzá, A García-Raja, A Conte.   

Abstract

The phytate urinary levels in a group of active calcium oxalate stone formers were studied and compared with those found in healthy people. Urinary phytate was significantly lower for stone formers. If deficit of the capacity to inhibit crystallization of calcium salts is considered an important factor related to calcium stone formation, the excretion of low phytate amounts could be an important risk factor in the development of this type of renal calculi. The influence of dietary phytate on urinary excretion was also studied. Clearly maintenance of a phytate-free diet significantly decreased the urinary excretion of phytate (about 50% after 36 h). This demonstrated the importance of dietary phytate in maintaining adequate urinary levels to permit effective crystallization inhibition of calcium salts and consequently preventing renal stone development.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10961468     DOI: 10.1080/003655900750016526

Source DB:  PubMed          Journal:  Scand J Urol Nephrol        ISSN: 0036-5599


  19 in total

1.  Mechanism of action of SNF472, a novel calcification inhibitor to treat vascular calcification and calciphylaxis.

Authors:  Joan Perelló; Miquel D Ferrer; Maria Del Mar Pérez; Nadine Kaesler; Vincent M Brandenburg; Geert J Behets; Patrick C D'Haese; Rekha Garg; Bernat Isern; Alex Gold; Myles Wolf; Carolina Salcedo
Journal:  Br J Pharmacol       Date:  2020-08-23       Impact factor: 8.739

Review 2.  Recent advances in nutritional research on urolithiasis.

Authors:  Roswitha Siener; Albrecht Hesse
Journal:  World J Urol       Date:  2005-11-08       Impact factor: 4.226

3.  Protective effect of myo-inositol hexaphosphate (phytate) on bone mass loss in postmenopausal women.

Authors:  Angel A López-González; Félix Grases; Nieves Monroy; Bartolome Marí; Ma Teófila Vicente-Herrero; Fernando Tur; Joan Perelló
Journal:  Eur J Nutr       Date:  2012-05-22       Impact factor: 5.614

4.  Potential thermodynamic and kinetic roles of phytate as an inhibitor of kidney stone formation: theoretical modelling and crystallization experiments.

Authors:  Saajidah Fakier; Allen Rodgers; Graham Jackson
Journal:  Urolithiasis       Date:  2019-02-14       Impact factor: 3.436

5.  Effect of Cystone® on urinary composition and stone formation over a one year period.

Authors:  S B Erickson; T J Vrtiska; J C Lieske
Journal:  Phytomedicine       Date:  2011-03-17       Impact factor: 5.340

6.  An experimental study on residual lithiasis after shock wave lithotripsy.

Authors:  A Costa-Bauzá; J Perelló; B Isern; F Grases
Journal:  Urol Res       Date:  2005-01-05

7.  Renal stone formation and development.

Authors:  F Grases; O Söhnel; A Costa-Bauzá
Journal:  Int Urol Nephrol       Date:  1999       Impact factor: 2.370

8.  First-time-in-human randomized clinical trial in healthy volunteers and haemodialysis patients with SNF472, a novel inhibitor of vascular calcification.

Authors:  J Perelló; P H Joubert; M D Ferrer; A Z Canals; S Sinha; C Salcedo
Journal:  Br J Clin Pharmacol       Date:  2018-10-03       Impact factor: 4.335

9.  On the origin of calcium oxalate monohydrate papillary renal stones.

Authors:  Fèlix Grases; Antonia Costa-Bauzá; Carlo R Bonarriba; Enrique C Pieras; Rafael A Fernández; Adrián Rodríguez
Journal:  Urolithiasis       Date:  2014-08-03       Impact factor: 3.436

10.  Nutritional aspect of nephrolithiasis.

Authors:  Anita Saxena; R K Sharma
Journal:  Indian J Urol       Date:  2010-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.